Select for export Self-reported negative outcomes of psilocybin users: A quantitative textual analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0229067 PubMed 32084160 Copy citation Copy BibTeX PLoS ONE 2020-02-20 Bheatrix Bienemann, Nina Stamato Ruschel, Maria Luiza Pesse Campos, Marco Aurélio Negreiros, Daniel C. Mograbi OpenAlex Published psilocybin DepressionAddictionTreatment-Resistant Depression Other More
Select for export Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2019.00955 PubMed 32038317 Copy citation Copy BibTeX Frontiers in Psychiatry 2020-01-21 Albert Garcia-Romeu, Alan K. Davis, Earth Erowid, Fire Erowid, Roland R. Griffiths, Matthew W. Johnson OpenAlex Published psilocybin AddictionChronic PainReceptor Pharmacology Observational Study More
Select for export Predicting the Efficacy of Psilocybin in Treating Mental Health and Addiction Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PDXScholar (Portland State University) 2019-12-31 Courtney Ledford OpenAlex Published psilocybinpsilocin AnxietyAddictionOCD Meta-Analysis More
Select for export Development of an improved psilocybin synthesis Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Uppsala University Publications (Uppsala University) 2019-12-31 Reham Shaba OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Mapping Psilocybin-Assisted Therapies: A Scoping Review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2019.12.04.19013896 Copy citation Copy BibTeX medRxiv 2019-12-11 Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University medRxiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export [Neurotrophic mechanisms of psychedelic therapy]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1051/jbio/2019015 PubMed 31829932 Copy citation Copy BibTeX Unknown journal 2019-12-11 Corne R, Mongeau R. Europe PMC Published psilocybin DepressionPTSDAddiction Review Article More
Select for export Cessation and reduction in alcohol consumption and misuse after psychedelic use. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119845793 PubMed 31084460 Copy citation Copy BibTeX Unknown journal 2019-05-13 Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Europe PMC Published psilocybin AddictionMystical ExperienceMeta-Analysis Meta-Analysis More
Select for export New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues No abstract availability was recorded for this entry. Details DOI 10.1007/s40429-019-00249-z Copy citation Copy BibTeX Current Addiction Reports 2019-04-22 Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, Laura Orsolini, Amira Guirguis, John Corkery OpenAlex Published psilocybin Receptor PharmacologyConsciousnessToxicity Other More
Select for export Attitudes Toward Medical Psychedelics Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Dominican Scholar (Dominican University of California) 2019-04-17 McKenna Silva OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export The Past and Future of Psychedelic Science: An Introduction to This Issue Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2019.1606472 PubMed 31132970 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2019-03-14 Richard Doblin, Merete Bruun Christiansen, Lisa Jerome, Brad Burge OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Furman University Scholar Exchange (Furman University) 2018-12-31 William G. Crane OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin induces aberrant prediction error processing for tactile mismatch responses No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2018.11.477 Copy citation Copy BibTeX European Neuropsychopharmacology 2018-12-31 P. Dürler OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1874467211666181010154139 PubMed 30318013 Copy citation Copy BibTeX Unknown journal 2018-12-31 Dinis-Oliveira RJ, Pereira CL, da Silva DD. Europe PMC Published psilocybin AddictionPharmacologyMechanism of Action Review Article More
Select for export Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pharmthera.2018.11.010 PubMed 30521880 Copy citation Copy BibTeX Unknown journal 2018-12-03 Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Europe PMC Published psilocybin DepressionAddictionEnd-of-Life Distress Review Article More
Select for export Psychedelic drugs in the treatment of anxiety, depression and addiction. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4045/tidsskr.17.1110 PubMed 30421744 Copy citation Copy BibTeX Unknown journal 2018-11-11 Kvam TM, Stewart LH, Andreassen OA. Europe PMC Published psilocybin DepressionAnxietyAddiction Animal Study More
Select for export DARK Classics in Chemical Neuroscience: Ibogaine. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.8b00294 PubMed 30216039 Copy citation Copy BibTeX Unknown journal 2018-10-08 Wasko MJ, Witt-Enderby PA, Surratt CK. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Serotonin, psychedelics and psychiatry Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/wps.20555 PubMed 30192100 Copy citation Copy BibTeX World Psychiatry 2018-09-06 Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Psychedelics as anti-inflammatory agents. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/09540261.2018.1481827 PubMed 30102081 Copy citation Copy BibTeX International Review of Psychiatry 2018-08-12 Flanagan TW, Nichols CD. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/374199 Copy citation Copy BibTeX bioRxiv 2018-07-24 Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionAddictionEnd-of-Life Distress Other More
Select for export DARK Classics in Chemical Neuroscience: Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.8b00186 PubMed 29956917 Copy citation Copy BibTeX Unknown journal 2018-07-15 Geiger HA, Wurst MG, Daniels RN. Europe PMC Published psilocybinpsilocin DepressionAddictionEnd-of-Life Distress Review Article More
